EconomicChina·22 Oct 2026
AstraZeneca to sell Chinese-developed cancer drug in the US
AI-summarized · Neutrality-checked
Global pharmaceutical firm AstraZeneca announced it would begin selling the Chinese-developed lung cancer drug sunvozertinib in the United States. The decision followed public criticism regarding the drug's limited availability, which compelled some American patients to travel to Shanghai to obtain the medicine after it received FDA approval in July 2025.…
Loading full story…
Sources and context
SCMP
NewspaperCompany ownedHong KongStandards published
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.